Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA
暂无分享,去创建一个
Jieqing Li | Q. Hao | W. Cao | J. Vadgama | Yong Wu | Y. Elshimali | Q. Geng | Ke Wu | P. Dutta | K. Schrode | Piwen Wang | Qiao-Hong Chen | M. Shaheen | Seyung S Chung | Donghui Zhu | Guanglin Chen | Qun Li | Kun Wang | W. Deng